CSL (ASX:CSL) Share Price Crosses Below Two Hundred Day Moving Average of $206.78
CSL Limited (ASX:CSL) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $206.78 and traded as low as $229.27. CSL shares last traded at $230.69, with a volume of 708,829 shares changing hands.
The company has a quick ratio of 1.09, a current ratio of 2.53 and a debt-to-equity ratio of 88.79. The business has a fifty day simple moving average of A$226.24 and a two-hundred day simple moving average of A$206.99. The company has a market capitalization of $104.53 billion and a price-to-earnings ratio of 54.59.
The business also recently disclosed a Final dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, October 11th will be issued a dividend of $1.478 per share. This represents a yield of 0.65%. The ex-dividend date of this dividend is Tuesday, September 10th. CSL’s payout ratio is 70.04%.
CSL Company Profile (ASX:CSL)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders.
Recommended Story: Does the Dogs of the Dow strategy work?
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.